To this end, it is significant that we detected suppressed mobility and invasiveness, as well as repressed expression of key molecular drivers of EMT, in STK25-deficient HepG2 cells, suggesting an additional mechanism underlying the lower HCC burden detected in Stk25-/- mice in vivo. The gene discussed is STK25; the disease is hepatocellular carcinoma.